Capricor Therapeutics (CAPR) Interest Coverage Ratio Growth (5y) (2018 - 2025)
Capricor Therapeutics (CAPR) Interest Coverage Ratio Growth (5y) (2018 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Capricor Therapeutics | 457.86 Mn | 457.86 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | -10.20% |
| Jun 30, 2025 | 1.33% |
| Mar 31, 2025 | -26.96% |
| Sep 30, 2024 | 62.25% |
| Jun 30, 2024 | 59.20% |
| Mar 31, 2024 | 43.49% |
| Mar 31, 2023 | -83.38% |
| Sep 30, 2022 | 56.94% |
| Jun 30, 2022 | 44.60% |
| Mar 31, 2022 | -22.07% |
| Dec 31, 2021 | 29.96% |
| Sep 30, 2021 | 57.31% |
| Sep 30, 2020 | 59.81% |
| Jun 30, 2020 | 60.30% |
| Mar 31, 2020 | 9.65% |
| Sep 30, 2019 | 10.34% |
| Jun 30, 2019 | -27.15% |
| Mar 31, 2019 | 34.28% |
| Mar 31, 2018 | 49.81% |